The company benefits from a dedicated support provided by Eurasanté Bio-Acceleration program, to maximise its chances of success on the French healthcare market. As a proof of the relevance of this project, Tada Medical achieved the SME Grand Slam, securing millions of Euros in funding from the three largest European programmes – EIC Accelerator, EIC Fast Track to Innovation and Eurostars-2. This is only managed by 0.0053% of companies in the market, and Tada Medical did it in the span of just one year.
Tada Medical has persevered to stay focussed on its vision to improve lives by providing innovative solutions for unmet healthcare needs. The grant money for each project is focused towards developing products for different application areas. ReLink® is the enabling platform technology supporting a family of products, each targeting a specific niche. Collectively, they provide for a wide portfolio of large scale, global and profitable markets for human and animal care, in hospital and homecare settings.